2011
DOI: 10.1021/cr100187n
|View full text |Cite
|
Sign up to set email alerts
|

Chemistry and Biology of Kahalalides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
69
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 68 publications
(69 citation statements)
references
References 76 publications
0
69
0
Order By: Relevance
“…KF is a promising anticancer compound that has been extracted from both Elysia rufescens and Bryopsis species (44). The bioactive compounds associated with E. rufescens are well investigated (45)(46)(47), and preliminary data revealed that two strains of Vibrio species isolated from E. rufescens produce the compound KF, with production confirmed by liquid chromatography-mass spectrometry (LCMS) and nuclear magnetic resonance (NMR) (48). However, recent attempts to isolate KF from cultured Vibrio strains have given inconsistent results, and more studies are needed to unequivocally determine the organism(s) responsible for the production of KF.…”
mentioning
confidence: 99%
“…KF is a promising anticancer compound that has been extracted from both Elysia rufescens and Bryopsis species (44). The bioactive compounds associated with E. rufescens are well investigated (45)(46)(47), and preliminary data revealed that two strains of Vibrio species isolated from E. rufescens produce the compound KF, with production confirmed by liquid chromatography-mass spectrometry (LCMS) and nuclear magnetic resonance (NMR) (48). However, recent attempts to isolate KF from cultured Vibrio strains have given inconsistent results, and more studies are needed to unequivocally determine the organism(s) responsible for the production of KF.…”
mentioning
confidence: 99%
“…The activity of KF was then investigated in Phase II clinical studies with patients having liver, non-small-cell lung cancer (Provencio et al, 2009) and melanoma. KF has also been tested in Phase II clinical trials for severe psoriasis (Gao and Hamann, 2011). IsoKF (elisidepsin, PM02734; Irvalec), the 4S-methylhexanoic isomer of KF, currently obtained via synthetic process, has been developed by PharmaMar in a Phase II clinical study (Serova et al, 2013).…”
Section: Kahalalide F: a Study In Chemical Ecology As A Starting Poinmentioning
confidence: 99%
“…The exposure of breast, vulval and hepatic human tumor cell lines to KF induced a downregulation of protein expression levels of ErbB3 (Janmaat et al, 2005). Detailed information on the biological activities, mechanism of action and clinical status of KF is provided in an excellent review (Gao and Hamann, 2011).…”
Section: Kahalalide F: a Study In Chemical Ecology As A Starting Poinmentioning
confidence: 99%
“…Unfortunately, the lead was dropped from phase II clinical trials due to a lack of efficacy despite results indicating a limited number of patients achieved a positive response. [11] The pharmacokinetic studies suggested that KF has a short half-life (approximately 30 min),[11] which could in part be the reason for its poor efficacy. However, no further studies have provided evidence of KF degradation products in vivo.…”
Section: Introductionmentioning
confidence: 99%